NITROGEN-CONTAINING HETEROARYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE MANUFACTURE OF MEDICAMENTS FOR TREATING, PREVENTING OR PRE-TREATING CONDITIONS MEDIATED BY HIF AND/OR ERYTHROPOIETIN
The present invention relates to compounds I suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo .